Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, has appointed Sharath Hegde, Ph.D. as the company’s new Chief Scientific Officer. Dr. Hegde brings over 30 ...
Tory Burch has helped thousands of women entrepreneurs through her eponymous foundation and its education programs, but very few recipients of her coveted one-year business fellowship have founded biotech ...
Fireside chats have become a staple of pandemic-era virtual events. The reasons are clear: they offer a glimpse into an otherwise private conversation and it’s entertaining to listen to ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
In this latest "Bloomberg Studio 1.0," host Emily Chang sits down with CRISPR co-inventor and 2020 Nobel Prize winner, Dr. Jennifer Doudna. They discuss her groundbreaking work on DNA, ...
Nearly a decade ago, when the first CRISPR companies started looking for capital, Behzad Aghazadeh passed.
Aghazadeh, one of biotech’s more opinionated investors, had invested in gene editing before, but ...
The pandemic year has been marked by so much tragedy, but I am heartened by what scientific innovation and collaboration have achieved to help move our society forward.
Last March, ...
When Jennifer Doudna won the Nobel Prize for Chemistry last year, there was no black-tie ceremony in Sweden. Because of the pandemic, she picked up the medal in her backyard.
Correspondent ...
When last year’s Nobel prize for chemistry was awarded to biochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 ...
In the spring of 2014, Jennifer Doudna had a nightmare.
The Berkeley biochemist had helped to invent a powerful new technology that made it possible to edit the human genome—an ...
In The Code Breaker, Walter Isaacson recounts the drama of the discovery in a digestible narrative that tackles the promise and the peril of Crispr.
For Isaacson, an accomplished storyteller of ...
Where do you take your career after you’ve won all of science’s biggest prizes? In this episode of Stereo Chemistry, C&EN executive editor Lisa Jarvis sits down with Nobel ...
Concert Health, a leading behavioral health medical group, today announced the closing of its Series A funding round at $14 million led by Vertical Venture Partners with participation from ...
The response to Covid-19 has been momentous but discoveries in AI, diet, conservation, space and beyond, show the power of science to improve the world post-pandemic
Genome-editing technology
This year finally ...
In February, Jennifer Doudna, one of America’s most prominent scientists, was still focused on CRISPR—the gene-editing tool that she’d co-discovered and that won her a Nobel Prize in October. But ...
TechCrunch has covered Noyo a few times in the last year. The startup builds APIs for the insurance market, a bit like what Plaid set out to do for ...
2020 Chemistry Nobel laureate Jennifer Doudna joins Fareed for a primer on CRISPR, a technology that allows for precise gene editing.
https://twitter.com/FareedZakaria/status/1333130472902234112
Focus
CRISPR
Client
UC Berkeley / IGI
WATCH THE ...
When Jennifer Doudna woke up, she realised her phone had been buzzing on and off for some time. It was still dark outside. In fact, her phone told her ...
CommonSpirit Health, a national nonprofit health system serving communities at more than 1,000 care sites and 137 hospitals across 21 states, today announced it is offering new access to ...
